IDIOPATHIC PULMONARY FIBROSIS (IPF)
Clinical trials for IDIOPATHIC PULMONARY FIBROSIS (IPF) explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC PULMONARY FIBROSIS (IPF) trials appear
Sign up with your email to follow new studies for IDIOPATHIC PULMONARY FIBROSIS (IPF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise for scarred lungs in early trial
Disease control CompletedThis study tested an oral drug called INS018_055 in 71 adults with idiopathic pulmonary fibrosis (IPF), a disease that scars the lungs and makes breathing hard. The main goal was to see if the drug is safe and tolerable over 12 weeks compared to a placebo. Researchers also measur…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS (IPF)
Phase: PHASE2 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated May 26, 2026 04:56 UTC
-
Arm test may reveal hidden limits in lung disease patients
Knowledge-focused CompletedThis study looked at 21 adults with idiopathic pulmonary fibrosis (IPF) to see if a simple arm exercise test (the 6-minute pegboard and ring test) relates to their ability to walk, do daily tasks, and feel less tired. Researchers measured arm endurance, leg strength, and breathin…
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS (IPF)
Sponsor: Marmara University • Aim: Knowledge-focused
Last updated May 20, 2026 12:08 UTC
-
Muscle loss linked to worse outcomes in lung disease patients
Knowledge-focused CompletedThis study looked at how muscle loss (sarcopenia) impacts quality of life and disease progression in 60 people with idiopathic pulmonary fibrosis (IPF). Researchers measured muscle strength, walking speed, and lung function, and used questionnaires to assess quality of life. The …
Matched conditions: IDIOPATHIC PULMONARY FIBROSIS (IPF)
Sponsor: Mersin University • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC